Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections

Young Kyung Yoon, Chan Soon Park, Jae Wook Kim, Kyurin Hwang, Sei Young Lee, Tae Hoon Kim, Do Yang Park, Hyun Jun Kim, Dong Young Kim, Hyun Jong Lee, Hyun Young Shin, Yong Kyu You, Dong Ah Park, Shin Woo Kim, Young Kyung Yoon, Chan Soon Park, Jae Wook Kim, Kyurin Hwang, Sei Young Lee, Tae Hoon Kim, Do Yang Park, Hyun Jun Kim, Dong Young Kim, Hyun Jong Lee, Hyun Young Shin, Yong Kyu You, Dong Ah Park, Shin Woo Kim

Abstract

These guidelines were developed as part of the 2016 Policy Research Servicing Project by the Korea Centers for Disease Control and Prevention. A multidisciplinary approach was taken to formulate this guideline to provide practical information about the diagnosis and treatment of adults with acute upper respiratory tract infection, with the ultimate aim to promote the appropriate use of antibiotics. The formulation of this guideline was based on a systematic literature review and analysis of the latest research findings to facilitate evidence-based practice, and focused on key questions to help clinicians obtain solutions to clinical questions that may arise during the care of a patient. These guidelines mainly cover the subjects on the assessment of antibiotic indications and appropriate selection of antibiotics for adult patients with acute pharyngotonsillitis or acute sinusitis.

Keywords: Antibiotics; Guideline; Pharyngitis; Rhinosinusitis; Tonsillitis.

Conflict of interest statement

No conflicts of interest.

Copyright © 2017 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy.

Figures

Figure 1
Figure 1
Flowchart for use of antibiotics for acute pharyngotonsillitis
Figure 2
Figure 2
How to take a throat swab. ① Press the tongue with a tongue depressor to reveal both palatine tonsils and uvula. ② Without touching the uvula, place a sterile swab deep inside the throat, past the uvula. ③ Gently stroke one palatine tonsil, posterior nasopharynx, and the other palatine tonsil, in the order specified. ④ Collect samples of lesions such as exudate in the area of sample collection. Be careful not to touch other areas in the mouth, such as the tongue and inner cheek, or to contaminate the swab with saliva. Immediately place the swab in a sterile tube and send it to the laboratory [26]
Figure 3
Figure 3
Flowchart for early use of empirical antibiotic therapy in patients with acute bacterial sinusitis

References

    1. Johnston S, , Holgate S. Epidemiology of viral respiratory infections. In: Myint S, Taylor-Robinson D, editors. Viral and other infections of the human respiratory tract. London: Chapman & Hall; 1996. pp. 1–38.
    1. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–494.
    1. Kirkpatrick GL. The common cold. Prim Care. 1996;23:657–675.
    1. Kim SW. Upper respiratory infections in adults. J Korean Med Assoc. 2010;53:10–19.
    1. Wessels MR. Streptococcal pharyngitis. N Engl J Med. 2011;364:648–655.
    1. Ebell MH, Smith MA, Barry HC, Ives K, Carey M. Does this patient have strep throat? JAMA. 2000;284:2912–2918.
    1. Wilson JF. In the clinic. Acute sinusitis. Ann Intern Med. 2010;153:ITC31-15. quiz ITC316.
    1. Chiappini E, Regoli M, Bonsignori F, Sollai S, Parretti A, Galli L, de Martino M. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther. 2011;33:48–58.
    1. Kim SW. Bacterial upper respiratory infections. Infect Chemother. 2011;43:383–389.
    1. Kocher JJ, Selby TD. Antibiotics for sore throat. Am Fam Physician. 2014;90:23–24.
    1. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:1279–1282.
    1. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, Taubert KA. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009;119:1541–1551.
    1. Cooper RJ, Hoffman JR, Bartlett JG, Besser RE, Gonzales R, Hickner JM, Sande MA, American Academy of Family Physicians American College of Physicians-American Society of Internal Medicine; Centers for Disease Control. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med. 2001;134:509–517.
    1. Little P, Stuart B, Hobbs FD, Butler CC, Hay AD, Delaney B, Campbell J, Broomfield S, Barratt P, Hood K, Everitt H, Mullee M, Williamson I, Mant D, Moore M, DESCARTE investigators Antibiotic prescription strategies for acute sore throat: a prospective observational cohort study. Lancet Infect Dis. 2014;14:213–219.
    1. Langlois DM, Andreae M. Group A streptococcal infections. Pediatr Rev. 2011;32:423–429.
    1. Komaroff AL, Pass TM, Aronson MD, Ervin CT, Cretin S, Winickoff RN, Branch WT., Jr The prediction of streptococcal pharyngitis in adults. J Gen Intern Med. 1986;1:1–7.
    1. Walsh BT, Bookheim WW, Johnson RC, Tompkins RK. Recognition of streptococcal pharyngitis in adults. Arch Intern Med. 1975;135:1493–1497.
    1. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1:239–246.
    1. Dobbs F. A scoring system for predicting group A streptococcal throat infection. Br J Gen Pract. 1996;46:461–464.
    1. McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998;158:75–83.
    1. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004;291:1587–1595.
    1. Dagnelie CF, van der Graaf Y, De Melker RA. Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract. 1996;46:589–593.
    1. Zwart S. 1, Sachs AP, Ruijs GJ, Gubbels JW, Hoes AW, de Melker RA. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults. BMJ. 2000;320:150–154.
    1. National Institute for Health and Clinical Excellence (NICE) Respiratory tract infections-antibiotic prescribing. London: NICE; 2008.
    1. McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. CMAJ. 2000;163:811–815.
    1. Windfuhr JP, Toepfner N, Steffen G, Waldfahrer F, Berner R. Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. Eur Arch Otorhinolaryngol. 2016;273:973–987.
    1. Gerber MA, Tanz RR, Kabat W, Dennis E, Bell GL, Kaplan EL, Shulman ST. Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis. An office-based, multicenter investigation. JAMA. 1997;277:899–903.
    1. Dagnelie CF, Bartelink ML, van der Graaf Y, Goessens W, de Melker RA. Towards a better diagnosis of throat infections (with group A beta-haemolytic streptococcus) in general practice. Br J Gen Pract. 1998;48:959–962.
    1. Roddey OF, Jr, Clegg HW, Martin ES, Swetenburg RL, Koonce EW. Comparison of an optical immunoassay technique with two culture methods for the detection of group A streptococci in a pediatric office. J Pediatr. 1995;126:931–933.
    1. Schlager TA, Hayden GA, Woods WA, Dudley SM, Hendley JO. Optical immunoassay for rapid detection of group A beta-hemolytic streptococci. Should culture be replaced? Arch Pediatr Adolesc Med. 1996;150:245–248.
    1. Hart AP, Buck LL, Morgan S, Saverio S, McLaughlin JC. A comparison of the BioStar Strep A OIA rapid antigen assay, group A Selective Strep Agar (ssA), and Todd-Hewitt broth cultures for the detection of group A Streptococcus in an outpatient family practice setting. Diagn Microbiol Infect Dis. 1997;29:139–145.
    1. Shin YJ, Jang SH, Dong ES, Ahn YM, Ku MS. Clinical manifestations of group A beta-hemolytic streptococcal pharyngitis and usefulness of tapid antigen yest. J Korean Pediatr Soc. 2001;44:732–740.
    1. Youn S, Chung HJ, Kim YH, Kim YH, Choi DJ, Lee SH, Min JS, Jung SY, Jung SK, Ahn BM, Lee HJ, Cha SH. Efficacy and cost benefits of rapid antigen detection test for group A streptococci obtained from acute pharyngitis in children. Korean J Pediatr Infect Dis. 2005;12:124–134.
    1. Song SK, Hong MA, Oh KC, Ahn SI, Tae MH, Shin HJ, Chang JK, Cha SH. Comparison of two rapid antigen detection tests for diagnosis of group A streptococcal pharyngotonsillitis. J Korean Pediatr Soc. 2002;45:973–979.
    1. Kim S. The evaluation of SD Bioline Strep A rapid antigen test in acute pharyngitis in pediatric clinics. Korean J Lab Med. 2009;29:320–323.
    1. Shet A, Kaplan EL. Clinical use and interpretation of group A streptococcal antibody tests: a practical approach for the pediatrician or primary care physician. Pediatr Infect Dis J. 2002;21:420–426.
    1. Kaplan EL, Top FH, Jr, Dudding BA, Wannamaker LW. Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis. 1971;123:490–501.
    1. Johnson DR, Kurlan R, Leckman J, Kaplan EL. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis. 2010;50:481–490.
    1. Christensen AM, Thomsen MK, Ovesen T, Klug TE. Are procalcitonin or other infection markers useful in the detection of group A streptococcal acute tonsillitis? Scand J Infect Dis. 2014;46:376–383.
    1. Hjortdahl P, Melbye H. Does near-to-patient testing contribute to the diagnosis of streptococcal pharyngitis in adults? Scand J Prim Health Care. 1994;12:70–76.
    1. Gulich M, Triebel T, Zeitler HP. Development and validation of a simple, two-step algorithm to identify streptococcal infection in adults with sore throat. Eur J Gen Pract. 2002;8:57–61.
    1. ESCMID Sore Throat Guideline Group Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P, Little P, Verheij T. Guideline for the management of acute sore throat. Clin Microbiol Infect. 2012;18(Suppl 1):1–28.
    1. Kaplan EL, Johnson DR, Del Rosario MC, Horn DL. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr Infect Dis J. 1999;18:1069–1072.
    1. Sayyahfar S, Fahimzad A, Naddaf A, Tavassoli S. Antibiotic susceptibility evaluation of group A streptococcus isolated from children with pharyngitis: a study from Iran. Infect Chemother. 2015;47:225–230.
    1. Chazan B, Raz R, Edelstein H, Kennes Y, Gal V, Colodner R. Susceptibility of group A streptococcus to antimicrobial agents in northern Israel: a surveillance study. Microb Drug Resist. 2015;21:551–555.
    1. Varaldo PE, Debbia EA, Nicoletti G, Pavesio D, Ripa S, Schito GC, Tempera G. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. Clin Infect Dis. 1999;29:869–873.
    1. Cha S, Lee H, Lee K, Hwang K, Bae S, Lee Y. The emergence of erythromycin-resistant Streptococcus pyogenes in Seoul, Korea. J Infect Chemother. 2001;7:81–86.
    1. Koh EH, Maeng KY, Kim S, Lee NY. A decrease in erythromycin resistance rate of Streptococcus pyogenes in 2004 in Jinju. Korean J Clin Microbiol. 2006;9:51–57.
    1. Koo H, Baek S, Ma S, Lee H, Cha S. Trends of the incidence of erythromycin-resistant group A streptococci in Korea from 1998 through 2002. Infect Chemother. 2004;36:75–82.
    1. Yi YH, Choi JH, Lee HK, Lee KJ, Bae SM, Yu JY, Kim KS. Characterization of erythromycin resistance of Streptococcus pyogenes isolated from pharyngitis patients in Korea. Jpn J Infect Dis. 2006;59:192–194.
    1. Lee HK, Lee J. Group A Streptococcus emm gene types in pharyngeal isolates during 2009–2011 in Korea. Health and Disease. 2012;5:58–63. Available at: . Accessed 25 December, 2017.
    1. Peyramond D, Portier H, Geslin P, Cohen R. 6-day amoxicillin versus 10-day penicillin V for group A beta-haemolytic streptococcal acute tonsillitis in adults: a French multicentre, open-label, randomized study. The French Study Group Clamorange. Scand J Infect Dis. 1996;28:497–501.
    1. Cohen R, Levy C, Doit C, De La Rocque F, Boucherat M, Fitoussi F, Langue J, Bingen E. Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 1996;15:678–682.
    1. Curtin-Wirt C, Casey JR, Murray PC, Cleary CT, Hoeger WJ, Marsocci SM, Murphy ML, Francis AB, Pichichero ME. Efficacy of penicillin vs. amoxicillin in children with group A beta hemolytic streptococcal tonsillopharyngitis. Clin Pediatr (Phila) 2003;42:219–225.
    1. Lennon DR, Farrell E, Martin DR, Stewart JM. Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis. Arch Dis Child. 2008;93:474–478.
    1. Clegg HW, Ryan AG, Dallas SD, Kaplan EL, Johnson DR, Norton HJ, Roddey OF, Martin ES, Swetenburg RL, Koonce EW, Felkner MM, Giftos PM. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial. Pediatr Infect Dis J. 2006;25:761–767.
    1. Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ. 1993;306:1170–1172.
    1. Feder HM, Jr, Gerber MA, Randolph MF, Stelmach PS, Kaplan EL. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics. 1999;103:47–51.
    1. Andrews M, Condren M. Once-daily amoxicillin for pharyngitis. J Pediatr Pharmacol Ther. 2010;15:244–248.
    1. Baltimore RS. Re-evaluation of antibiotic treatment of streptococcal pharyngitis. Curr Opin Pediatr. 2010;22:77–82.
    1. Rimoin AW, Hoff NA, Fischer Walker CL, Hamza HS, Vince A, Abdel Rahman N, Andrasevic S, Emam S, Vukelic D, Elminawi N, Abdel Ghafar H, da Cunha AL, Qazi S, Gardovska D, Steinhoff MC. Treatment of streptococcal pharyngitis with once-daily amoxicillin versus intramuscular benzathine penicillin G in low-resource settings: a randomized controlled trial. Clin Pediatr (Phila) 2011;50:535–542.
    1. Eslami ST, Nassirian A, Nassirian H, Hatami E, Sobhani E, Najibpour R. Comparing performance of amoxicillin and intramuscular benzathine penicillin in relieving manifestations of streptococcal pharyngitis in children. Ghana Med J. 2014;48:185–188.
    1. Matthys J. A primary antibiotic treatment for acute streptococcal tonsillitis. Am J Med. 2009;122:e7. author reply e9.
    1. Patel NN, Patel DN. Acute exudative tonsillitis. Am J Med. 2009;122:18–20.
    1. Brunton S, Pichichero M. Considerations in the use of antibiotics for streptococcal pharyngitis. J Fam Pract. 2006;(Suppl):S9–S16.
    1. Armengol CE, Hendley JO. Occurrence of group A beta-hemolytic streptococcal pharyngitis in the four months after treatment of an index episode with amoxicillin once-daily or twice-daily or with cephalexin. Pediatr Infect Dis J. 2012;31:1124–1127.
    1. Kaplan EL, Johnson DR. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr. 1988;113:400–403.
    1. Brook I. Treatment of patients with acute recurrent tonsillitis due to group A β-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium. J Antimicrob Chemother. 1989;24:227–233.
    1. Cherry JD. Pharyngitis (pharyngitis, tonsillitis, tonsillopharyngirls, and nasopharyngitis) In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL, editors. Textbook of pediatric infectious diseases. 5th ed. Philadelphia: WB Saunders; 2004. pp. 161–170.
    1. Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev. 2007;20:622–659.
    1. Flores AR, Caserta MT. Pharyngitis. In: Bennett JE, Dolin R, Dlaser MJ, editors. Mandell, Doublas, and Bennett's principles and practice of infectious diseases. 8th ed. Philadelphia, PA: Elsevier; 2015. p. 758.
    1. Holm SE. Reasons for failures in penicillin treatment of streptococcal tonsillitis and possible alternatives. Pediatr Infect Dis J. 1994;13(1 Suppl 1):S66–S69. discussion S78-9.
    1. Lildholdt T, Doessing H, Lyster M, Outzen KE. The natural history of recurrent acute tonsillitis and a clinical trial of azithromycin for antibiotic prophylaxis. Clin Otolaryngol Allied Sci. 2003;28:371–373.
    1. Hur JK. Upper respiratory infections in children. J Korean Med Assoc. 2010;53:5–9.
    1. Esposito S, De Ritis G, D'Errico G, Noviello S, Ianniello F. Clinical comparison of cefaclor twice daily versus amoxicillin-clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis. Clin Ther. 1998;20:72–79.
    1. Haczyński J, Bardadin J, Gryczyńska D, Gryczyński M, Gołabek W, Kawalski H, Kaźmierczak H, Krecicki T, Kubik P, Namysłowski G, Popiel L. A comparative study of cefaclor vs. amoxicillin/clavulanate in tonsillopharyngitis. Med Sci Monit. 2001;7:1016–1022.
    1. Esposito S, Marchisio P, Bosis S, Droghetti R, Mattina R, Principi N, Short Therapy Study Group Comparative efficacy and safety of 5-day cefaclor and 10-day amoxycillin treatment of group A streptococcal pharyngitis in children. Int J Antimicrob Agents. 2002;20:28–33.
    1. Ozaki T, Nishimura N, Suzuki M, Narita A, Watanabe N, Ahn J, Koyama N, Ushida H, Nakane K, Yasuda N, Funahashi K. Five-day oral cefditoren pivoxil versus 10-day oral amoxicillin for pediatric group A streptococcal pharyngotonsillitis. J Infect Chemother. 2008;14:213–218.
    1. Aksit S, Caglayan S, Dokucu G. Seasonal benzathine penicillin G prophylaxis for recurrent streptococcal pharyngitis in children. Acta Paediatr Jpn. 1998;40:256–258.
    1. Mora R, Salami A, Mora F, Cordone MP, Ottoboni S, Passali GC, Barbieri M. Efficacy of cefpodoxime in the prophylaxis of recurrent pharyngotonsillitis. Int J Pediatr Otorhinolaryngol. 2003;67(Suppl 1):S225–S228.
    1. Ungkanont K, Yellon RF, Weissman JL, Casselbrant ML, González-Valdepeña H, Bluestone CD. Head and neck space infections in infants and children. Otolaryngol Head Neck Surg. 1995;112:375–382.
    1. Larawin V, Naipao J, Dubey SP. Head and neck space infections. Otolaryngol Head Neck Surg. 2006;135:889–893.
    1. Kilty SJ, Gaboury I. Clinical predictors of peritonsillar abscess in adults. J Otolaryngol Head Neck Surg. 2008;37:165–168.
    1. Hsiao HJ, Huang YC, Hsia SH, Wu CT, Lin JJ. Clinical features of peritonsillar abscess in children. Pediatr Neonatol. 2012;53:366–370.
    1. Lepelletier D, Pinaud V, Le Conte P, Bourigault C, Asseray N, Ballereau F, Caillon J, Ferron C, Righini C, Batard E, Potel G, French PTA Study Group Peritonsillar abscess (PTA): clinical characteristics, microbiology, drug exposures and outcomes of a large multicenter cohort survey of 412 patients hospitalized in 13 French university hospitals. Eur J Clin Microbiol Infect Dis. 2016;35:867–873.
    1. Centor RM. Expand the pharyngitis paradigm for adolescents and young adults. Ann Intern Med. 2009;151:812–815.
    1. Pham TT, Burchette JL, Jr, Hale LP. Fatal disseminated adenovirus infections in immunocompromised patients. Am J Clin Pathol. 2003;120:575–583.
    1. Bonnet F, Neau D, Viallard JF, Morlat P, Ragnaud JM, Dupon M, Legendre P, Imbert Y, Lifermann F, Le Bras M, Beylot J, Longy-Boursier M. Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults. Ann Med Interne (Paris) 2001;152:227–235.
    1. Korea Centers for Disease Prevention and Control (KCDC) Guideline for antibiotic use in children with acute upper respiratory infection, 2016. [Accessed 25 December, 2017]. Available at: .
    1. Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR, American Academy of Family Physicians American College of Physicians-American Society of Internal Medicine; Centers for Disease Control. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med. 2001;134:506–508.
    1. Shulman ST, Gerber MA. So what's wrong with penicillin for strep throat? Pediatrics. 2004;113:1816–1819.
    1. Choby BA. Diagnosis and treatment of streptococcal pharyngitis. Am Fam Physician. 2009;79:383–390.
    1. Tan T, Little P, Stokes T, Guideline Development Group Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance. BMJ. 2008;337:a437.
    1. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, Orlandi RR, Palmer JN, Patel ZM, Peters A, Walsh SA, Corrigan MD. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(Suppl):S1–S39.
    1. Rosenfeld RM. Acute sinusitis in adults. N Engl J Med. 2016;375:962–970.
    1. Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, Eisenberg S, Ganiats TG, Gelzer A, Hamilos D, Haydon RC, 3rd, Hudgins PA, Jones S, Krouse HJ, Lee LH, Mahoney MC, Marple BF, Mitchell CJ, Nathan R, Shiffman RN, Smith TL, Witsell DL. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007;137(Suppl):S1–S31.
    1. Masood A, Moumoulidis I, Panesar J. Acute rhinosinusitis in adults: an update on current management. Postgrad Med J. 2007;83:402–408.
    1. Koh YI. Diagnosis of allergic rhinitis. Korean J Med. 2013;85:452–456.
    1. Gwaltney JM., Jr Acute community-acquired sinusitis. Clin Infect Dis. 1996;23:1209–1223.
    1. Puhakka T, Mäkelä MJ, Alanen A, Kallio T, Korsoff L, Arstila P, Leinonen M, Pulkkinen M, Suonpää J, Mertsola J, Ruuskanen O. Sinusitis in the common cold. J Allergy Clin Immunol. 1998;102:403–408.
    1. Berg O, Carenfelt C, Rystedt G, Anggård A. Occurrence of asymptomatic sinusitis in common cold and other acute ENT-infections. Rhinology. 1986;24:223–225.
    1. Gwaltney JM, Jr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol. 1992;90:457–461.
    1. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program. Am J Med. 2001;111(Suppl 9A):19S–24S.
    1. Burgstaller JM, Steurer J, Holzmann D, Geiges G, Soyka MB. Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review. Eur Arch Otorhinolaryngol. 2016;273:1067–1077.
    1. Gwaltney JM., Jr Acute community acquired bacterial sinusitis: To treat or not to treat. Can Respir J. 1999;6(Suppl A):46A–50A.
    1. Gwaltney JM, Jr, Wiesinger BA, Patrie JT. Acute community-acquired bacterial sinusitis: the value of antimicrobial treatment and the natural history. Clin Infect Dis. 2004;38:227–233.
    1. Ioannidis JP, Lau J. Technical report: evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children: a systematic overview. Pediatrics. 2001;108:E57.
    1. Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ, Hicks LA, Pankey GA, Seleznick M, Volturo G, Wald ER, File TM, Jr, Infectious Diseases Society of America IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54:e72–e112.
    1. Williams JW, Jr, Aguilar C, Cornell J, Chiquette ED, Makela M, Holleman DR, Simel DL. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev. 2003:CD000243.
    1. Ip S, Fu L, Balk E, Chew P, Devine D, Lau J. Update on acute bacterial rhinosinusitis. Evid Rep Technol Assess (Summ) 2005:1–3.
    1. Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA, Craig WA, Sinus And Allergy Health Partnership Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2004;130:1–45.
    1. American Academy of Pediatrics Subcommittee on Management of Sinusitis and Committee on Quality Improvement. Clinical practice guideline: management of sinusitis. Pediatrics. 2001;108:798–808.
    1. Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA, American Academy of Family Physicians American College of Physicians-American Society of Internal Mediciine; Centers for Disease Control; Infectious Diseases Society of America. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med. 2001;134:498–505.
    1. Benninger MS, Sedory Holzer SE, Lau J. Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis: summary of the Agency for Health Care Policy and Research evidence-based report. Otolaryngol Head Neck Surg. 2000;122:1–7.
    1. Hadley JA, Mösges R, Desrosiers M, Haverstock D, van Veenhuyzen D, Herman-Gnjidic Z. Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis. Laryngoscope. 2010;120:1057–1062.
    1. Ahovuo-Saloranta A, Rautakorpi UM, Borisenko OV, Liira H, Williams JW, Jr, Mäkelä M. Antibiotics for acute maxillary sinusitis in adults. Cochrane Database Syst Rev. 2014:CD000243.
    1. Henry DC, Riffer E, Sokol WN, Chaudry NI, Swanson RN. Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. Antimicrob Agents Chemother. 2003;47:2770–2774.
    1. Luterman M, Tellier G, Lasko B, Leroy B. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis. Ear Nose Throat J. 2003;82:576–580. 582–584.
    1. Low DE, Desrosiers M, McSherry J, Garber G, Williams JW, Jr, Remy H, Fenton RS, Forte V, Balter M, Rotstein C, Craft C, Dubois J, Harding G, Schloss M, Miller M, McIvor RA, Davidson RJ. A practical guide for the diagnosis and treatment of acute sinusitis. CMAJ. 1997;156(Suppl 6):S1–S14.
    1. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol. 1988;105:343–349.
    1. Jenkins SG, Farrell DJ, Patel M, Lavin BS. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3. J Infect. 2005;51:355–363.
    1. Falagas ME, Karageorgopoulos DE, Grammatikos AP, Matthaiou DK. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol. 2009;67:161–171.
    1. Lemiengre MB, van Driel ML, Merenstein D, Young J, De Sutter AI. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev. 2012;10:CD006089.
    1. Jacobs MR. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther. 2008;6:619–635.
    1. Lynch JP, 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med. 2010;16:217–225.
    1. Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP, Dimopoulos G, Falagas ME. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ. 2008;178:845–854.
    1. Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009;63:511–519.
    1. Desrosiers M, Evans GA, Keith PK, Wright ED, Kaplan A, Bouchard J, Ciavarella A, Doyle PW, Javer AR, Leith ES, Mukherji A, Robert Schellenberg R, Small P, Witterick IJ. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2011;40(Suppl 2):S99–S193.
    1. Wald ER. Sinusitis. Pediatr Ann. 1998;27:811–818.
    1. Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Gimeno M, Coronel P. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin. J Chemother. 2008;20:175–179.
    1. Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Martín-Herrero JE. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae . Eur J Clin Microbiol Infect Dis. 2008;27:75–80.
    1. Sader HS, Jacobs MR, Fritsche TR. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. Diagn Microbiol Infect Dis. 2007;57(Suppl):5S–12S.
    1. Jansen WT, Verel A, Beitsma M, Verhoef J, Milatovic D. Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada. Curr Med Res Opin. 2008;24:2853–2861.
    1. Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. J Antimicrob Chemother. 2007;60:323–327.
    1. Poachanukoon O, Kitcharoensakkul M. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial. Clin Ther. 2008;30:1870–1879.
    1. Kim SH, Bae IK, Park D, Lee K, Kim NY, Song SA, Kim HR, Jeon GW, Urm SH, Shin JH. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing invasive and noninvasive pneumococcal diseases in Korea from 2008 to 2014. Biomed Res Int. 2016;2016:6950482.
    1. Han SB, Kim JH, Kang JH, Ma SH, Kim CS, Kim KH, Kim HM, Choi YY. Recent epidemiology of Streptococcus pneumoniae in nasopharynxes of Korean children with acute otitis media. J Infect Chemother. 2017;23:136–141.
    1. Gidengil CA, Kruskal BA, Lee GM. Initial antibiotic choice in the treatment of group A streptococcal pharyngitis and return visit rates. J Pediatric Infect Dis Soc. 2013;2:361–367.
    1. Blackburn RM, Henderson KL, Lillie M, Sheridan E, George RC, Deas AH, Johnson AP. Empirical treatment of influenza-associated pneumonia in primary care: a descriptive study of the antimicrobial susceptibility of lower respiratory tract bacteria (England, Wales and Northern Ireland, January 2007-March 2010) Thorax. 2011;66:389–395.
    1. Zhanel GG, Palatnick L, Nichol KA, Bellyou T, Low DE, Hoban DJ. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother. 2003;47:1867–1874.
    1. Zhanel GG, Palatnick L, Nichol KA, Low DE, Hoban DJ, CROSS Study Group Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother. 2003;47:1875–1881.
    1. Ludlam HA, Enoch DA. Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK? Int J Antimicrob Agents. 2008;32:101–105.
    1. Mokabberi R, Haftbaradaran A, Ravakhah K. Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia. J Clin Pharm Ther. 2010;35:195–200.
    1. Peck KR. Appropriate use of antibiotics for the treatment of acute upper respiratory tract infections in adults. J Korean Med Assoc. 2006;49:553–558.
    1. Brook I. Acute and chronic bacterial sinusitis. Infect Dis Clin North Am. 2007;21:427–448. [vii.]
    1. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 1997;117:S1–S7.
    1. Leung R, Almassian S, Kern R, Conley D, Tan B, Chandra R. Patient level decision making in recurrent acute rhinosinusitis: a cost-benefit threshold for surgery. Laryngoscope. 2013;123:11–16.
    1. Wilson KF, McMains KC, Orlandi RR. The association between allergy and chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2014;4:93–103.
    1. Slavin RG, Spector SL, Bernstein IL, Kaliner MA, Kennedy DW, Virant FS, Wald ER, Khan DA, Blessing-Moore J, Lang DM, Nicklas RA, Oppenheimer JJ, Portnoy JM, Schuller DE, Tilles SA, Borish L, Nathan RA, Smart BA, Vandewalker ML, American Academy of Allergy, Asthma and Immunology American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol. 2005;116(Suppl):S13–S47.
    1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de, Y, Wormald PJ. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;23:1–298. 3 p preceding table of contents.
    1. Stachler RJ. Comorbidities of asthma and the unified airway. Int Forum Allergy Rhinol. 2015;5(Suppl 1):S17–S22.
    1. Stevens WW, Peters AT. Immunodeficiency in chronic sinusitis: recognition and treatment. Am J Rhinol Allergy. 2015;29:115–118.
    1. Younis RT, Lazar RH, Anand VK. Intracranial complications of sinusitis: a 15-year review of 39 cases. Ear Nose Throat J. 2002;81:636–638.
    1. Peters AT, Spector S, Hsu J, Hamilos DL, Baroody FM, Chandra RK, Grammer LC, Kennedy DW, Cohen NA, Kaliner MA, Wald ER, Karagianis A, Slavin RG. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014;113:347–385.
    1. Gallagher RM, Gross CW, Phillips CD. Suppurative intracranial complications of sinusitis. Laryngoscope. 1998;108:1635–1642.
    1. American Academy of Pediatrics Subcommittee on Management of Sinusitis and Committee on Quality Improvement. Clinical practice guideline: management of sinusitis. Pediatrics. 2001;108:798–808.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever